Is rivaroxaban safer and more effective than warfarin in patients with atrial fibrillation and stroke or TIA? Reply

Research output: Contribution to journal › Letter › peer-review

Access to Document

@article{a4772d842eac4855985e98e5c04d455b,

title = "Is rivaroxaban safer and more effective than warfarin in patients with atrial fibrillation and stroke or TIA? Reply",

author = "Hankey, {Graeme J.}",

year = "2012",

month = aug,

doi = "10.1016/S1474-4422(12)70157-6",

language = "English",

volume = "11",

pages = "660--661",

journal = "The Lancet Neurology",

issn = "1474-4422",

publisher = "Academic Press",

number = "8",

}